Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017:2017:1936315.
doi: 10.1155/2017/1936315. Epub 2017 Apr 16.

Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease

Gilles Duvoisin  1   2 , Robert N Lopez  2 , Andrew S Day  3 , Daniel A Lemberg  2 , Richard B Gearry  4 , Steven T Leach  5
Affiliations
Review

Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease

Gilles Duvoisin et al. Mediators Inflamm. 2017.

Abstract

There is increasing importance placed upon noninvasive assessment of gut inflammation. These tools are likely to be the key in differentiating intestinal inflammatory disease from functional disorders and in monitoring the response to intervention in individuals with known inflammatory conditions. Although various noninvasive markers are currently available, they have limitations and do not provide ideal utility. This review focuses on emerging markers of gut inflammation, highlighting the potential of specific markers.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Huicho L., Campos M., Rivera J., Guerrant R. L. Fecal screening tests in the approach to acute infectious diarrhea: a scientific overview. The Pediatric Infectious Disease Journal. 1996;15(6):486–494. doi: 10.1097/00006454-199606000-00004. - DOI - PubMed
    1. Lopez R. N., Leach S. T., Lemberg D. A., Duvoisin G., Gearry R. B., Day A. S. Faecal biomarkers in inflammatory bowel disease. Journal of Gastroenterology and Hepatology. 2016;32(3):577–582. doi: 10.1111/jgh.13611. - DOI - PubMed
    1. Chung-Faye G., Hayee B., Maestranzi S., Donaldson N., Forgacs I., Sherwood R. Fecal M2-pyruvate kinase (M2-PK): a novel marker of intestinal inflammation. Inflammatory Bowel Diseases. 2007;13(11):1374–1378. doi: 10.1002/ibd.20214. - DOI - PubMed
    1. Czub E., Herzig K.-H., Szaflarska-Popawska A., et al. Fecal pyruvate kinase: a potential new marker for intestinal inflammation in children with inflammatory bowel disease. Scandinavian Journal of Gastroenterology. 2007;42(10):1147–1150. doi: 10.1080/00365520701320513. - DOI - PubMed
    1. Walkowiak J., Banasiewicz T., Krokowicz P., Hansdorfer-Korzon R., Drews M., Herzig K.-H. Fecal pyruvate kinase (M2-PK): a new predictor for inflammation and severity of pouchitis. Scandinavian Journal of Gastroenterology. 2005;40(12):1493–1494. doi: 10.1080/00365520500319112. - DOI - PubMed

LinkOut - more resources